Results 61 to 70 of about 7,842 (116)

Regarding "Challenges in diagnosing thrombotic thrombocytopenic purpura". [PDF]

Hematol Transfus Cell Ther
Martins de Oliveira Filho C, Carney BJ.
europepmc   +1 more source

Evolución de la nomenclatura de los factores del sistema de antígenos leucocitarios humanos

Revista Cubana de Hematología, Inmunología y Hemoterapia
La nomenclatura del sistema de antígenos leucocitarios humanos (HLA, del inglés human leukocyte antigens) ha sido objeto de numerosas modificaciones según se han descubierto y caracterizado sus factores.
Arturo Chang-Monteagudo, Antonio A Bencomo-Hernández, Luz Mirella Morera-Barrios, Catalino Ustáriz-García, Odalis de la Guardia-Peña   +4 more
doaj  

Immune cell dynamics, cytokines, and extracellular vesicles in systemic inflammatory response syndrome (SIRS): a multiparametric analysis. [PDF]

J Transl Med
Martí-Chillón GJ, Muntión S, Flores-Montero J, González-Robledo J, Corchete L, Pozo J, Osugui L, Preciado S, Gómez-Redondo M, Blanco JF, Navarro-Bailón A, Sagredo V, Almeida J, Orfao A, Sánchez-Guijo F.   +14 more
europepmc   +1 more source

Molecular Characterization of Three Novel Large Deletions Causing α⁰-Thalassemia. [PDF]

Int J Mol Sci
Ferrer-Benito S, Ricard Andrés MP, Murúzabal MJ, Nieto JM, González FA, Ortega-Montero B, Villegas A, Benavente C, Ropero P.   +8 more
europepmc   +1 more source

Howell-Jolly-like inclusions in granulocytes of a liver transplant recipient. [PDF]

Hematol Transfus Cell Ther
Roldán Galiacho V, Hormaza de Jauregui S, Elicegui Fernández L.   +2 more
europepmc   +1 more source

Reply to Omansen, T.F.; Ramharter, M. Intensive Therapeutic Plasma Exchange for Severe Yellow Fever: What Is the Evidence? Comment on "Ho et al. Intensive Therapeutic Plasma Exchange-New Approach to Treat and Rescue Patients with Severe Form of Yellow Fever. <i>Trop. Med. Infect. Dis.</i> 2025, <i>10</i>, 39". [PDF]

Trop Med Infect Dis
Ho YL, Nukui Y, Villaça PR, Okazaki E, Tatsui NH, Netto LC, Joelsons D, da Rocha TRF, de Mello Malta F, Pinho JRR, Segurado AAC, Rocha V.   +11 more
europepmc   +1 more source

Genetic evolution and relapse-associated mutations in adult T-cell acute lymphoblastic leukemia patients treated in PETHEMA trials. [PDF]

Hemasphere
González-Gil C, Lopes T, Morgades M, Fuster-Tormo F, Montesinos P, Medina CR, Hermosín L, González-Martínez T, Queipo MP, González-Campos J, Martínez-Sánchez P, Díaz-Beya M, Coll R, Maluquer C, Zamora L, Artola T, Vall-Llovera F, Tormo M, Torrent A, Martínez-Laperche C, Gil-Cortés C, Barba P, Cervera M, Ribera J, Fernández-Delgado M, Ayala R, Cladera A, Mateos MC, Vidal MJ, Feliu J, Torres A, Azaceta G, Calasanz MJ, Bigas A, Esteller M, Orfao A, Ribera JM, Genescà E.   +37 more
europepmc   +1 more source

Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk. [PDF]

Br J Haematol
Marín-Quílez A, Sánchez-Fuentes A, Zamora-Cánovas A, Gómez-González PL, Diaz-Ajenjo L, Benito R, Rodríguez-Alén A, Sevivas T, Murciano T, Murillo L, Butta NV, Revilla N, Campos R, Escribano P, Esteve J, Fernández-Mosteirin N, Ferrer-Marín F, Hernández L, Huerta-Aragonés J, León A, López-Duarte M, López E, Martín-Salces M, Nomdedeu M, Oña R, Peláez-Pleguezuelos I, Ramos F, Sebastián E, Serrano C, Sierra-Aisa C, Vidal-Laso R, González-Porras JR, Lozano ML, Bastida JM, Rivera J.   +34 more
europepmc   +1 more source

First report of perioperative iptacopan interruption in paroxysmal nocturnal hemoglobinuria without breakthrough hemolysis. [PDF]

Hematol Transfus Cell Ther
Tokuda K, Morioka T, Arai S, Matsuo T, Matsumoto K, Shirasaki R, Ooi J, Tashiro H.   +7 more
europepmc   +1 more source

Cost-Effectiveness analysis of the 21-Gene platform for guiding treatment decisions for early Hormone-Positive breast cancer: the perspective of the Brazilian public health system. [PDF]

BMC Health Serv Res
de Iracema Gomes Cubero D, Fonseca FLA, da Costa Aguiar Alves Reis B, de Alcantara Sousa LV, Maselli-Schoueri JH, da Giglio A.   +5 more
europepmc   +1 more source